Beyond trial and error: Tailoring drug therapies to patients’ DNA
Doctors can use patients’ DNA to select suitable medications, reducing trial and error and the risk of adverse reactions.
More news
- Breast cancer myths are costing women their lives, experts warn
- Sentencing of motorist who caused life-changing injuries to Louth doctor adjourned because of solicitors’ strike
- The $25m promise that could change cancer treatment in New Zealand
- Hospital Universitário da UFV: MEC libera R$ 2,5 milhões para projeto
- Ракетный удар по Харькову: пострадали девять человек